145 related articles for article (PubMed ID: 36016614)
1. Growth hormone associated with treatment efficacy of immune checkpoint inhibitors in gastric cancer patients.
Zhao Y; Ji Z; Li J; Zhang S; Wu C; Zhang R; Guo Z
Front Oncol; 2022; 12():917313. PubMed ID: 36016614
[TBL] [Abstract][Full Text] [Related]
2. Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients.
Zhang J; Wang L; Zhang S; Cao R; Zhao Y; Zhao Y; Song Y; Guo Z
BMC Cancer; 2024 Feb; 24(1):266. PubMed ID: 38408930
[TBL] [Abstract][Full Text] [Related]
3. Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer?
Zhang X; Xu S; Wang J; Lv Y; Wang N; Lai R; Sha Z; Zhao Q; Guo Z
BMC Cancer; 2022 Nov; 22(1):1136. PubMed ID: 36335320
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia Was a Poor Prognostic Predictor for Patients With Advanced Lung Cancer Treated With Immune Checkpoint Inhibitors.
Li S; Liu Z; Ren Y; Liu J; Lv S; He P; Yang Y; Sun Y; Chang J; Luo D; Cong M
Front Nutr; 2022; 9():900823. PubMed ID: 35923193
[TBL] [Abstract][Full Text] [Related]
5. Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes.
Chen L; Sun H; Zhao R; Huang R; Pan H; Zuo Y; Zhang L; Xue Y; Song H; Li X
Front Pharmacol; 2022; 13():836958. PubMed ID: 35308215
[No Abstract] [Full Text] [Related]
6. The Prognostic Value of Pre-treatment Hemoglobin (Hb) in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy.
Gou M; Zhang Y; Liu T; Qu T; Si H; Wang Z; Yan H; Qian N; Dai G
Front Oncol; 2021; 11():655716. PubMed ID: 34211839
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic efficacy analysis of immunotherapy in small cell lung cancer].
Zhong J; Zheng QW; Zhao J; Wang ZP; Wu MN; Zhuo ML; Wang YY; Li JJ; Yang X; Chen HX; An TT
Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):771-776. PubMed ID: 32988161
[No Abstract] [Full Text] [Related]
8. Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors.
Hou B; Wang P; Liu T; Chen S; Li T; Zhang S; Tao H; Li X; Hu Y
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101748. PubMed ID: 34182184
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ predicts the treatment efficiency of immune checkpoint inhibitors in cancer patients.
Liu J; Ma J; Xing N; Ji Z; Li J; Zhang S; Guo Z
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3043-3050. PubMed ID: 35852620
[TBL] [Abstract][Full Text] [Related]
10. Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors.
Che H; Xiong Q; Ma J; Chen S; Wu H; Xu H; Hou B
BMC Cancer; 2022 Aug; 22(1):904. PubMed ID: 35986342
[TBL] [Abstract][Full Text] [Related]
11. An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer.
Wang KW; Wang MD; Li ZX; Hu BS; Wu JJ; Yuan ZD; Wu XL; Yuan QF; Yuan FL
Front Immunol; 2022; 13():992060. PubMed ID: 36311733
[TBL] [Abstract][Full Text] [Related]
12. Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors.
Zhao D; Mambetsariev I; Li H; Chen C; Fricke J; Fann P; Kulkarni P; Xing Y; Lee PP; Bild A; Massarelli E; Koczywas M; Reckamp K; Salgia R
Lung Cancer; 2020 Aug; 146():174-181. PubMed ID: 32554069
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Peripheral Blood Parameters and Immune-Related Adverse Events with the Efficacy of Immune Checkpoint Inhibitors.
Bai R; Li L; Chen X; Chen N; Song W; Zhang Y; Lv Z; Han F; Zhao Y; Li W; Cui J
J Oncol; 2021; 2021():9935076. PubMed ID: 34335763
[TBL] [Abstract][Full Text] [Related]
14. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Efficacy and Safety of Third-Line Treatments for Advanced Gastric Cancer: A Systematic Review With Bayesian Network Meta-Analysis.
Huang M; Li J; Yu X; Xu Q; Zhang X; Dai X; Li S; Sheng L; Huang K; Liu L
Front Oncol; 2021; 11():734323. PubMed ID: 34745955
[TBL] [Abstract][Full Text] [Related]
16. Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy.
Pan S; Yu Y; Wang S; Tu B; Shen Y; Qiu Q; Liu X; Su N; Zuo Y; Luan J; Zhang JY; Shi M; Meng F; Wang FS
Front Immunol; 2022; 13():892618. PubMed ID: 35711409
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors.
Chen L; Zhao R; Sun H; Huang R; Pan H; Zuo Y; Zhang L; Xue Y; Li X; Song H
Front Pharmacol; 2022; 13():833584. PubMed ID: 35795575
[No Abstract] [Full Text] [Related]
18. Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma.
Sun M; Ji H; Xu N; Jiang P; Qu T; Li Y
BMC Cancer; 2022 Jul; 22(1):762. PubMed ID: 35831785
[TBL] [Abstract][Full Text] [Related]
19. How to Choose a Survival Period? The Impact of Antibiotic Use on OS or PFS in NSCLC Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Chen H; Han KD; He ZJ; Huang YS
Technol Cancer Res Treat; 2021; 20():15330338211033498. PubMed ID: 34323149
[TBL] [Abstract][Full Text] [Related]
20. Circulating neutrophils activated by cancer cells and M2 macrophages promote gastric cancer progression during PD-1 antibody-based immunotherapy.
Zhou C; Guo L; Cai Q; Xi W; Yuan F; Zhang H; Yan C; Huang L; Zhu Z; Zhang J
Front Mol Biosci; 2023; 10():1081762. PubMed ID: 37333017
[No Abstract] [Full Text] [Related]
[Next] [New Search]